๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Wuhu
Clinical trial register · China

Clinical Trials in Wuhu, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
First Affiliated Hospital of Wannan Medical College25 Beijing InnoCare Pharma Tech Co., Ltd.5 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.5 Eli Lilly and Company5 Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.3
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Wuhu

91 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Clinical Trial of TQA3605 Tablet in Combination With Nucleos(t)Ide Analogues(NAs) Versus NAs Alone for the Treatment of Patients With Chronic Hepatitis B Virus Infection Who Have Undergone Treatment and Exhibit Low Viral Load or Poor Response
NCT07797231Chronic Hepatitis B
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
930
Hefei, Wuhu, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Wuwei
2026-09
Not yet open
Efficacy and Safety of Roflumilast Foam 0.3% in Trial Participants With Seborrheic Dermatitis
NCT07683806Seborrheic Dermatitis
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 3
309
Bengbu, Wuhu, Fuzhou, Xiamen, Guangzhou, Shenzhen, Haikou, Baoding
2026-08-24
Not yet open
Effects of Esmolol on Sublingual Microcirculation and Vascular Waterfall Phenomenon in Patients With Septic Shock
NCT07657754Septic Shock, Sepsis, Critical Illness Sepsis, Severe
First Affiliated Hospital of Wannan Medical College
Not applicable
20
Wuhu, Bengbu
2026-08-01
Not yet open
Effects of Dexmedetomidine on Sublingual Microcirculation and Vascular Waterfall Phenomenon in Patients With Septic Shock
NCT07657715Septic Shock, Sepsis, Critical Illness
First Affiliated Hospital of Wannan Medical College
Not applicable
20
Bengbu, Wuhu
2026-08-01
Not yet open
Effects of Anisodamine on Sublingual Microcirculation and Vascular Waterfall Phenomenon in Patients With Septic Shock
NCT07657702Septic Shock, Sepsis, Critical Illness
First Affiliated Hospital of Wannan Medical College
Not applicable
20
Wuhu
2026-08-01
Not yet open
Papaverine and Sublingual Microcirculation in Septic Shock
NCT07657741Septic Shock, Microcirculatory Dysfunction, Sublingual Microcirculation, Hemodynamic Instability
First Affiliated Hospital of Wannan Medical College
Not applicable
20
Bengbu, Wuhu
2026-08-01
Not yet open
EIT Evaluation of Different Antihypertensive Agents on the Ventilation-Perfusion Ratio in Patients With Acute Respiratory Failure
NCT07603037Acute Respiratory Failure (ARF), Hypertension, Pulmonary Perfusion Imbalance, Aortic Dissection (Subset)
First Affiliated Hospital of Wannan Medical College
Not applicable
12
Wuhu
2026-07-15
Not yet open
Effect of Shenfu Injection on the Vascular Waterfall Phenomenon in Patients With Septic Shock
NCT07603024Septic Shock
First Affiliated Hospital of Wannan Medical College
Not applicable
20
Wuhu
2026-07-01
Not yet open
Case-Based Learning for Bedside Lung Ultrasound Teaching in ICU
NCT07594470Medical Education, ICU, Emergency Medicine, Lung Ultrasound
First Affiliated Hospital of Wannan Medical College
Not applicable
106
Wuhu
2026-07-01
Not yet open
Shear Wave Elastography of Peripheral Nerves for Early Diagnosis of ICU-acquired Weakness
NCT07594249ICU-acquired Weakness, Critical Illness Polyneuropathy, Critical Illness Myopathy
First Affiliated Hospital of Wannan Medical College
Observational
98
Wuhu
2026-07-01
Not yet open
Effects of Exercise Sequence and Meal Sequence on Weight Management Among Children and Adolescents With Overweight or Obesity: The STEP Trial
NCT07712068Obesity & Overweight, Insulin Resistance, Inflamation
Peking University
Not applicable
480
Wuhu, Zhengzhou, Shenyang, Zibo, Shanghai, Hangzhou, Jinhua, Beijing
2026-07
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics and Clinical Activity of BBT001 Following Intravenous Administration in Participants With Chronic Spontaneous Urticaria (CSU)
NCT07717905Chronic Spontaneous Urticaria
Bambusa Therapeutics
Phase 1/2
48
Wuhu, Beijing, Guangzhou, Shijiazhuang, Jinzhou, Wuxi, Taiyuan, Xiโ€™an
2026-06-29
Recruiting
Delayed Versus Early Antihyperglycemic Treatment for Severe Stroke
NCT07501533Severe Stroke
First Affiliated Hospital of Wannan Medical College
Phase 2
200
Wuhu
2026-06-18
Recruiting
Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD
NCT07632677Type 2 Diabetes Mellitus (T2DM), MASH - Metabolic Dysfunction-Associated Steatohepatitis, Metabolic Dysfunction-associated Fatty Liver Disease
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
10,000
Bengbu, Hefei, Wuhu, Guangzhou, Shenzhen, Nanning, Zunyi, Haikou
2026-05-15
Not yet open
Ongericimab Injection Reducing Recurrence of Ischemic Stroke
NCT07242599Ischemic Cerebral Infarction
Beijing Tiantan Hospital
Phase 3
4,810
Fuyang, Wuhu, Beijing, Chongqing, Ningde, Dingxi, Jiuquan, Lanzhou
2026-04-22
Recruiting
Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma.
NCT07385703Adenocarcinoma
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 3
752
Hefei, Wuhu, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Wuwei
2026-04-15
Recruiting
Phase โ…ข Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN
NCT07390123IgA Nephropathy (IgAN)
Haisco Pharmaceutical Group Co., Ltd.
Phase 3
370
Huangshan City, Wuhu, Beijing, Zhanjiang, Changsha, Changchun, Linyi, Shanghai
2026-04-07
Not yet open
Simulation and Feasibility Study of Drone-Delivered AED for Out-of-Hospital Cardiac Arrest
NCT07508774Out-of-Hospital Cardiac Arrest (Simulated)
Ye Sheng
Not applicable
24
Wuhu
2026-04-01
Not yet open
A Clinical Study Evaluating the Efficacy and Safety of CMS-D001 Tablets in the Treatment of Adult Patients With Moderate to Severe Plaque-type Psoriasis
NCT07432854Moderate to Severe Plaque Psoriasis
Dermavon Holdings Limited
Phase 2/3
540
Bengbu, Wuhu, Guangzhou, Chengde, Handan, Shijiazhuang, Harbin, Nanyang
2026-03-03
Recruiting
Study of the Efficacy and Safety of ICP-332 in Participants With Chronic Spontaneous Urticaria
NCT07378527Chronic Spontaneous Urticaria (CSU)
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 2/3
344
Bengbu, Wuhu, Beijing, Chongqing, Fuzhou, Guangzhou, Shijiazhuang, Luoyang
2026-02-13
Recruiting
A Study of Brenipatide in Adult Participants With Schizophrenia
NCT07410507Schizophrenia
Eli Lilly and Company
Phase 2
450
Changsha, Chengdu, Hangzhou, Suzhou, Tianjin, Wuhu, Xi'an, Zhumadian
2026-02-10
Recruiting
A Study of Choydar Flow-Directed Mesh Stent in the Treatment of Unruptured Intracranial Aneurysms
NCT07228312Intracranial Aneurysm
Johnson & Johnson Medical (Shanghai) Ltd.
Observational
200
Chenzhou, Guangzhou, Nanjing, Nanyang, Taiyuan, Wuhu, Zhengzhou
2026-01-28
Recruiting
Hemoadsorption for Severe Ischemic Stroke
NCT07127484Ischemic Stroke, Hemoadsorption
First Affiliated Hospital of Wannan Medical College
Not applicable
116
Wuhu
2026-01-05
Recruiting
Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2
NCT07263308Acute Ischemic Stroke
Capital Medical University
Phase 3
1,192
Anqing, Bozhou, Fuyang, Maโ€™anshan, Suzhou, Wuhu, Beijing, Fuzhou
2025-12-18
Recruiting
Non-invasive Ultrasound and Hematoma Clearance After Intracerebral Hemorrhage
NCT07246473Intracerebral Hemorrhage
Beijing Tiantan Hospital
Not applicable
86
Wuhu, Beijing
2025-12-12
Recruiting
Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis
NCT07236099Prurigo Nodularis (PN)
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 2
135
Wuhu, Beijing, Chongqing, Fuzhou, Guangzhou, Shijiazhuang, Jingzhou, Changsha
2025-11-27
Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naรฏve.
NCT07028853Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate
Pfizer
Phase 3
1,000
Wuhu, Beijing, Chongqing, Lanzhou, Guangzhou, Wuhan, Changsha, Huai'an
2025-09-28
Active, closed
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytrudaยฎ in Multiple Resected Solid Tumors
NCT07160335Non-small Cell Lung Cancer, Melanoma, Renal Cell Carcinoma
Shanghai Henlius Biotech
Phase 1
174
Hefei, Wuhu, Beijing, Hunan, Fuzhou, Xiamen, Lanzhou, Cangzhou
2025-09-26
Recruiting
A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer
NCT07043725HER2-positive Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 3
544
Bengbu, Hefei, Wuhu, Beijing, Chongqing, Quanzhou, Xiamen, Zhangzhou
2025-09-15
Recruiting
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)
NCT07239947Atopic Dermatitis
Bambusa Therapeutics
Phase 1
99
Hefei, Wuhu, Beijing, Guangzhou, Changsha, Wuxi, Zhenjiang, Nanchang
2025-08-09
Recruiting
Rescue Endovascular Treatment After Neurological Deterioration in Initially Mild Basilar Artery Occlusion in an Extended Time Window
NCT06843356Acute Mild Ischemic Stroke, Basilar Artery Occlusion, Rescue Endovascular Treatment, Extended Time Window
First Affiliated Hospital of Wannan Medical College
Not applicable
159
Hefei, Wuhu
2025-08-01
Not yet open
A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults
NCT07083739Primary Immune Thrombocytopenia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2
320
Hefei, Wuhu, Beijing, Chongqing, Lanzhou, Guangzhou, Shenzhen, Zhanjiang
2025-08
Recruiting
Focused Ultrasound Spleen Stimulation and Inflammation in Septic Shock
NCT06990295Septic Shock, Inflammatory Cytokines, Spleen Neuromodulation, Focused Ultrasound
First Affiliated Hospital of Wannan Medical College
Not applicable
40
Wuhu
2025-07-25
Recruiting
Safety and Efficacy of Ventricular Irrigation for Ventriculitis
NCT06358209Central Nervous System Infections
RenJi Hospital
Not applicable
310
Hefei, Wuhu, Beijing, Fuzhou, Guangzhou, Shenzhen, Zhongshan, Harbin
2025-07-01
Recruiting
ICP-332 in Subjects With Non-segmental Vitiligo
NCT07047612Non Segmental Vitiligo
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 2/3
603
Wuhu, Beijing, Chongqing, Fuzhou, Guangzhou, Shijiazhuang, Luoyang, Nanyang
2025-05-09
Recruiting
A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia
NCT06900920Primary Immune Thrombocytopenia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
199
Hefei, Wuhu, Beijing, Chongqing, Lanzhou, Guangzhou, Shenzhen, Zhanjiang
2025-04-30
Recruiting
Cerebral Large Vessel Occlusion Stroke Multiomics Biosample Cohort
NCT06963489Large Vessel Occlusion, Acute Ischemic Stroke
First Affiliated Hospital of Wannan Medical College
Observational
500
Wuhu, Baotou, Jinan, Henan, Beijing
2025-04-27
Not yet open
Shenfu Injection Modulates Carotid Elasticity in Septic Shock
NCT06915506Septic Shock, Vascular Dysfunction, Arterial Stiffness, Carotid Artery Elasticity Alterations
First Affiliated Hospital of Wannan Medical College
Phase 4
48
Wuhu
2025-04-15
Recruiting
Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis
NCT06842199Plaque Psoriasis Patients
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 3
383
Hefei, Wuhu, Beijing, Chongqing, Fuzhou, Guangzhou, Liuzhou, Guiyang
2025-03-20
Recruiting
Clinical Trial of TQB2825 Injection Combined With Chemotherapy in Subjects With Diffuse Large B-cell Lymphoma
NCT06854445Diffuse Large Cell B-lymphoma
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 2
55
Wuhu, Xiamen, Lanzhou, Guangzhou, Nanning, Shijiazhuang, Harbin, Zhengzhou
2025-03-12
Not yet open
Induced Pluripotent Stem Cell Derived Exosomes Nasal Drops for the Treatment of Stable Vitiligo
NCT06810869Stable Vitiligo
Second Affiliated Hospital of Wannan Medical College
Phase EARLY_PHASE1
29
Wuhu
2025-02-05
Recruiting
Pleth Variability Index for Predicting Low Blood Pressure During Maintenance Hemodialysis
NCT07022847Hypotension and Shock, Hemodialysis, End-Stage Renal Disease Requiring Haemodialysis, Intradialytic Hypotension
First Affiliated Hospital of Wannan Medical College
Observational
200
Wuhu
2025-02-01
Recruiting
Predictive Value of Carotid Ultrasonography for Intradialytic Hypotension
NCT07033260Intradialytic Hypotension, End-Stage Renal Disease Requiring Haemodialysis, Uremia; Chronic, Hemodialysis
First Affiliated Hospital of Wannan Medical College
Observational
183
Wuhu
2025-02-01
Recruiting
Inferior Vena Cava Collapsibility Index and Intradialytic Hypotension
NCT07033273End-Stage Renal Disease Requiring Haemodialysis, Intradialytic Hypotension
First Affiliated Hospital of Wannan Medical College
Observational
188
Wuhu
2025-01-27
Not yet open
A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis
NCT06767540Atopic Dermatitis
Akeso
Phase 3
198
Wuhu, Beijing, Chongqing, Dongguan, Guangzhou, Jiangmen, Shenzhen, Zhuhai
2025-01-23
Recruiting
Assessment of the Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients With Major Depressive Disorder
NCT06692361Major Depressive Disorder (MDD), Depression - Major Depressive Disorder
Gang Wang
Not applicable
214
Wuhu, Beijing, Guangzhou, Shijiazhuang, Jining, Chengdu, Tianjin, Dali
2025-01-01
Recruiting
A Two-Part, Phase 3 Study Evaluating the Efficacy and Safety of WS016 for the Treatment of Hyperkalemia
NCT07251309Hyperkalemia
Waterstone Pharmaceutical (Wuhan) Co., LTD.
Phase 3
420
Bengbu, Wuhu, Chongqing, Xiamen, Lanzhou, Guangzhou, Zhanjiang, Huizhou
2024-12-23
Recruiting
A Randomized Trial of Imaging Selection Modalities for Stroke Thrombectomy (NO-SELECT)
NCT05230914Stroke, Ischemic, Stroke, Acute
Xinqiao Hospital of Chongqing
Not applicable
1,846
Wuhu, Chongqing, Jiangmen, Haikou, Huai'an, Wuxi, Jingdezhen, Dalian
2024-12-12
Recruiting
Pleural Strain by Speckle-Tracking Ultrasound: Feasibility and Driving Pressure Associations
NCT06911450Ventilation, Mechanical, ARDS (Acute Respiratory Distress Syndrome)
First Affiliated Hospital of Wannan Medical College
Observational
75
Wuhu
2024-12-05
Recruiting
The Addictive Diagnostic Value of Apparent Diffusion Coefficients to bpMRI in the Diagnosis of Prostate Cancer
NCT06737588Prostate Cancer
Anhui Provincial Hospital
Observational
600
Hefei, Wuhu
2024-12-01
Recruiting
ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis
NCT06775860Atopic Dermatitis
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 3
552
Hefei, Wuhu, Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Shaoguan
2024-11-14
Recruiting
The Clinical Trial of TQB2102 for Injection Against Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer
NCT06452706Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 2
42
Bozhou, Chuzhou, Hefei, Maโ€™anshan, Wuhu, Harbin, Zhengzhou, Wuhan
2024-11-14
Not yet open
The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM).
NCT06606509Type1 Diabetes Mellitus
Nanjing First Hospital, Nanjing Medical University
Observational
1,000
Anqing, Bengbu, Hefei, Wuhu, Beijing, Chongqing, Fuzhou, Quanzhou
2024-11-07
Recruiting
Changes in Regional Ventilation-Perfusion Match Following Percutaneous Transluminal Angioplasty for Arteriovenous Graft Thrombosis
NCT07613632Arteriovenous Graft Thrombosis, End Stage Renal Disease on Dialysis
First Affiliated Hospital of Wannan Medical College
Observational
20
Wuhu
2024-10-24
Recruiting
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
NCT06629779Metastatic Castration-Resistant Prostate Cancer
Pfizer
Phase 3
900
Wuhu, Beijing, Fuzhou, Guangzhou, Shantou, Guilin, Xinxiang, Zhengzhou
2024-10-22
Active, closed
A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).
NCT06551324Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Pfizer
Phase 3
600
Wuhu, Beijing, Chongqing, Fuzhou, Lanzhou, Guangzhou, Guilin, Wuhan
2024-10-21
Active, closed
Regular Physical Exercise in Patients With Symptomatic Intracranial Arterial Stenosis
NCT06615726Ischemic Stroke, Transient Ischemic Attack
Capital Medical University
Phase 3
1,300
Fuyang, Huainan, Suzhou, Wuhu, Beijing, Chongqing, Zhangzhou, Foshan
2024-10-10
Active, closed
To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis
NCT06552520Atopic Dermatitis
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 3
500
Bengbu, Tongling, Wuhu, Beijing, Chongqing, Xiamen, Guangzhou, Shenzhen
2024-10-08
Recruiting
The Preventive Effect of Shenfu Injection on Myocardial Dysfunction in Sepsis
NCT06898723Septic Cardiomyopathy, Septic Shock
First Affiliated Hospital of Wannan Medical College
Phase 4
440
Wuhu
2024-10-01
Recruiting
The Feasibility of Pulmonary Perfusion Assessment Using Sodium Bicarbonate Contrast With Electrical Impedance Tomography: A Prospective Pilot Study
NCT07542366Acute Respiratory Failure, Acute Respiratory Distress Syndrome (ARDS), Pneumonia, Critical Illness
First Affiliated Hospital of Wannan Medical College
Observational
41
Wuhu
2024-09-26
Recruiting
POASAC Study (Preoperative Anemia Severity and Classification Study)
NCT06499974Anemia
Peking Union Medical College Hospital
Observational
1,000
Wuhu, Beijing, Zhangzhou, Zunyi, Chifeng, Hohhot
2024-08-02
Active, closed
Methylprednisolone Adjunctive to Endovascular Thrombectomy for Stroke
NCT06360458Acute Ischemic Stroke, Large Infarct Core
Wan-Jin Chen
Phase 3
928
Hefei, Taihe Chengguanzhen, Wuhu, Anxi, Fuqing, Fuzhou, Longyan, Nanping
2024-08-01
Recruiting
Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed Shock
NCT06351150Vasodilatory Shock
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
214
Hefei, Wuhu, Beijing, Chongqing, Fuzhou, Lanzhou, Guangzhou, Qingyuan
2024-07-23
Recruiting
Local Liver Treatment for Multi-organ Colorectal Cancer Metastases
NCT06449937Metastatic Colorectal Carcinoma, Multi-organ Metastatic Colorectal Cancer, Metastatic Malignant Neoplasm in the Liver
Anhui Provincial Hospital
Not applicable
130
Chuzhou, Fuyang, Hefei, Maโ€™anshan, Wuhu
2024-07
Active, closed
A Multicenter, Phase 3 Study of IBI343 Monotherapy Versus Treatment of Investigator's Choice in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, HER2-negative, Gastric or Gastroesophageal Junction Adenocarcinoma (G-HOPE-001)
NCT06238843Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3
464
Bengbu, Hefei, Lu'an, Wuhu, Beijing, Fuzhou, Lanzhou, Dongguan
2024-06-30
Recruiting
Probucol for Symptomatic Intracranial and Extracranial Artery Stenosis
NCT06225752Ischemic Stroke, TIA
First Affiliated Hospital of Wannan Medical College
Phase 3
5,452
Wuhu
2024-06-15
Recruiting
IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes
NCT06118840Intracranial Aneurysm, CT Angiography, Deep Learning, Double Bind Interaction
Jinling Hospital, China
Not applicable
6,450
Hefei, Wuhu, Guiyang, Zhengzhou, Shiyan, Nanjing, Xuzhou, Changchun
2024-05-20
Active, closed
A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic Dermatitis
NCT06280716Atopic Dermatitis
Eli Lilly and Company
Phase 3
301
Wuhu, Beijing, Chongqing, Xiamen, Guangzhou, Shenzhen, Haikou, Shijiazhuang
2024-04-24
Recruiting
The Efficacy and Safety of Y-3 Intracalvariosseous Injection Versus Intravenous Injection in the Treatment of Acute Large Hemispheric Infarction
NCT06374667Stroke, Acute Ischemic, Blood-Brain Barrier
yilong Wang
Not applicable
134
Wuhu, Beijing, Tangshan, Xi'an, Tianjin
2024-04-22
Recruiting
Endovascular Therapy Versus Best Medical Treatment for Acute Large Vessel Occlusion Stroke With Low NIHSS
NCT06143488Acute Ischemic Stroke, Mild Neurocognitive Disorder, Thrombectomy
First Affiliated Hospital of Wannan Medical College
Not applicable
264
Wuhu
2024-02-07
Recruiting
A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer
NCT06215950Ovarian Cancer, Cervix Cancer, Metastatic Cancer, Advanced Cancer
Chongqing Precision Biotech Co., Ltd
Phase 1
36
Wuhu
2024-01-10
Recruiting
Rescue Endovascular Therapy for Progressive Acute Mild Ischemic Stroke With Large Vascular Occlusion
NCT06155032Stroke, Ischemic, Cerebrovascular; Disorder, Occlusive
First Affiliated Hospital of Wannan Medical College
Not applicable
272
Fuyang, Hefei, Huainan, Huangshan City, Suzhou, Wuhu, Xiangyang
2024-01-04
Active, closed
Endovascular Treatment of Cerebrovascular Diseases Guided by Optical Coherence Tomography (OCT) Technology๏ผˆCVD-OCT๏ผ‰
NCT06986330Carotid Stenosis, Optical Coherence Tomography (OCT), Endovascular Treatment
First Affiliated Hospital of Wannan Medical College
Observational
200
Wuhu
2023-11-30
Not yet open
A Study of AK104/Tislelizumab With Chemotherapy as First-line Treatment in PD-L1 TPS < 1% Non-small Cell Lung Cancer
NCT05990127Locally Advanced or Metastatic NSCLC
Akeso
Phase 3
642
Bengbu, Hefei, Wuhu, Beijing, Chongqing, Fuzhou, Zhangzhou, Lanzhou
2023-11-14
Recruiting
Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes๏ผˆCAR-T๏ผ‰ for CEA Positive Advanced Malignant Solid Tumors
NCT06126406Gastric Cancer, Colon Cancer, Rectal Cancer, Breast Cancer
Chongqing Precision Biotech Co., Ltd
Phase 1
60
Wuhu
2023-11-06
Recruiting
A Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma
NCT06049290Relapsed/Refractory Multiple Myeloma
Nanjing Leads Biolabs Co.,Ltd
Phase 1/2
342
Wuhu, Beijing, Xiamen, Guangzhou, Shenzhen, Guiyang, Haikou, Luoyang
2023-10-20
Recruiting
A Study of Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease
NCT05837897Crohn's Disease
Takeda
Phase 3
408
Hefei, Wuhu, Beijing, Fuzhou, Lanzhou, Foshan, Guangzhou, Huizhou
2023-06-16
Not yet open
YK-029A as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations
NCT05767892Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Suzhou Puhe Pharmaceutical Technology Co., LTD
Phase 3
350
Bengbu, Hefei, Wuhu, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou
2023-05-01
Active, closed
A Study of Telitacicept for IgA Nephropathy (TELIGAN)
NCT05799287Primary IgA Nephropathy
RemeGen Co., Ltd.
Phase 3
318
Bengbu, Hefei, Wuhu, Beijing, Chongqing, Xiamen, Lanzhou, Guangzhou
2023-04-28
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
Abivax S.A.
Phase 3
1,116
Wuhu, Beijing, Fuzhou, Guangzhou, Luoyang, Zhengzhou, Wuhan, Shenyang
2023-01-16
Recruiting
A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors
NCT05458219Locally Advanced Unresectable or Metastatic Solid Tumors
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
470
Hefei, Wuhu, Beijing, Fuzhou, Guangzhou, Zhengzhou, Wuhan, Changsha
2022-10-26
Active, closed
A Study of LY3484356 in Chinese Participants With Advanced Breast Cancer
NCT05509790Breast Neoplasms
Eli Lilly and Company
Phase 1
17
Wuhu, Changsha, Nanchang, Shanghai
2022-10-09
Recruiting
China HeadAche DIsorders RegiStry
NCT05334927Headache Disorders, Primary, Migraine, New Daily Persistent Headache, Medication Overuse Headache
Beijing Tiantan Hospital
Observational
10,000
Anqing, Wuhu, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Shenzhen
2022-08-29
Active, closed
To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast Cancer
NCT05365178HR-positive, HER2-negative Breast Neoplasms
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
432
Bengbu, Wuhu, Beijing, Chongqing, Fuzhou, Lanzhou, Wuwei, Guangzhou
2022-07-01
Active, closed
A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjetaยฎ in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancer
NCT05346224Breast Cancer, Breast Neoplasms, HER2-positive Breast Cancer
Shanghai Henlius Biotech
Phase 3
900
Bengbu, Hefei, Lu'an, Maโ€™anshan, Wuhu, Beijing, Chongqing, Chongqi
2022-04-25
Active, closed
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)
NCT05288166Prostatic Neoplasms, Neoplasm Metastasis, Urogenital Neoplasms, Physiological Effects of Drugs
Eli Lilly and Company
Phase 3
925
Bengbu, Hefei, Wuhu, Beijing, Guangzhou, Harbin, Wuhan, Changsha
2022-04-14
Active, closed
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
NCT05100862Relapsed/Refractory Follicular Lymphoma, Marginal Zone Lymphoma
BeOne Medicines
Phase 3
799
Wuhu, Beijing, Chongqing, Fuzhou, Xiamen, Foshan, Guangzhou, Huizhou
2022-03-10
Not yet open
Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasโ„ข BRS System
NCT04995159Coronary Heart Disease
Lepu Medical Technology (Beijing) Co., Ltd.
Not applicable
2,150
Bengbu, Hefei, Wuhu, Beijing, Chongqing, Lanzhou, Foshan, Guangzhou
2021-09
Recruiting
S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC๏ผ‰
NCT03941561Gastric Cancer
Fudan University
Phase 3
1,006
Anqing, Hangzhou, Hefei, Nanchang, Shanghai, Wuhu
2019-01-01
Active, closed
A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer
NCT03706365Prostate Cancer
Eli Lilly and Company
Phase 2/3
393
Hefei, Wuhu, Lanzhou, Guangzhou, Harbin, Luoyang, Wuhan, Changsha
2018-11-26
Recruiting
China Health Big Data
NCT03699228Osteoporosis, Obesity, Liver Steatoses
Beijing Jishuitan Hospital
Observational
30,000
Wuhu, Beijing, Guiyang, Zhengzhou, Shanghai
2017-12-01
Rows per page Showing 1–91 of 91
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/wuhu

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 91 of those studies with a site in Wuhu.

How many clinical trials are recruiting in Wuhu?

53 of the 91 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 22 have not yet opened recruitment, 16 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Wuhu), 91 studies
PhaseStudiesRecruitingShare
Phase 3321435.2%
Not applicable221224.2%
Observational161317.6%
Phase 1646.6%
Phase 2656.6%
Phase 2/3424.4%
Phase 1/2222.2%
Phase 4212.2%
Phase EARLY_PHASE1101.1%

Most active sponsors

Lead sponsors with the most studies (Wuhu)
Lead sponsorStudiesRecruiting
First Affiliated Hospital of Wannan Medical College2515
Beijing InnoCare Pharma Tech Co., Ltd.55
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.52
Eli Lilly and Company51
Beijing Tiantan Hospital32
Pfizer32
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.32
Akeso20
Anhui Provincial Hospital22
Bambusa Therapeutics22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.